← Open Payments lookup

MARY GARCIA-HOLGUIN: Open Payments

NPI 1306857966 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,009 in 112 payments from 17 companies in 2025. Trend: 2023 $5,491 · 2024 $3,807 · 2025 $4,009

Food & beverage: $3,897Education: $112
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.18$960
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$782
Otsuka America Pharmaceutical, Inc.16$461
Supernus Pharmaceuticals, Inc.12$325
E.R. Squibb & Sons, L.L.C.6$292
Vanda Pharmaceuticals Inc.6$201
Axsome Therapeutics, Inc.5$194
Lundbeck LLC8$164
Janssen Pharmaceuticals, Inc2$152
Alkermes, Inc.2$130

Products named: CAPLYTA, REXULTI, UZEDY, AUSTEDO XR, Qelbree, COBENFY, FANAPT, Auvelity.

Industry payments across TX — which companies pay providers there.